DNA Damage Response Pathway Overview
The DNA damage response (DDR) pathway is a complex, evolutionarily conserved network of cellular processes that detect, signal, and repair various forms of DNA damage to maintain genome integrity. It is activated in response to both endogenous and exogenous sources of DNA damage. The DDR coordinates cell cycle checkpoints, DNA repair mechanisms, transcriptional programs, senescence induction, or apoptosis depending on the extent of the damage. Key components include sensors (e.g., MRN complex, RPA, Ku70/80), signal transducers (e.g., ATM, ATR, DNA-PKcs), and effectors (e.g., CHK1/CHK2 kinases; p53 tumor suppressor; BRCA1/BRCA2; RAD51; CDK inhibitors like p21). Major repair pathways within the DDR include homologous recombination (HR), non-homologous end joining (NHEJ), nucleotide excision repair (NER), mismatch repair (MMR), and base excision repair (BER). Defects in DDR components can lead to cancer and other diseases. Many cancer therapies target the DDR to enhance tumor cell killing or protect normal cells.
Mechanism of Action
Various, including inhibition of kinases (e.g., ATM, ATR, CHK1/2), interference with DNA repair mechanisms (e.g., PARP inhibition), or modulation of protein-protein interactions (e.g., MDM2 inhibition)
Biological Functions
Disease Associations
Safety Considerations
- Potential for off-target effects due to the complexity of the pathway
- Development of resistance to targeted therapies
- Increased risk of secondary malignancies
- Myelosuppression
- Gastrointestinal toxicities
Interacting Drugs
Associated Biomarkers
Biomarker |
---|
BRCA1/BRCA2 mutation status |
ATM expression level |
ATR expression level |
p53 status |
Expression levels of DDR pathway genes |